Recombinant antibody technology has been leveraged to mitigate a range of common problems associated with hybridoma platforms, helping to facilitate the development of an entirely new class of ...

Boster Biological Technology is revolutionizing molecular biology with its advanced recombinant protein expression and custom antibody services, offering high-quality solutions for global research and ...

The production of antibodies has thus far been limited to a small number of species, most often murine, which has led to availability and scalability challenges for scientists. Technology Networks ...

The development of early monoclonal antibody (mAb) therapies centered around the hybridoma platform requires the production of target antigen or immunogen and animal immunizations. This means there ...

PALO ALTO, Calif. & CAMBRIDGE, England--(BUSINESS WIRE)--Today, Open Monoclonal Technology, Inc. (OMT) and Recombinant Antibody Technology, Ltd (RAT) announced a ...

Recombinant antibody technology has addressed many problems associated with hybridoma-based platforms, opening the door to a new class of biologics. Today, this technology continues to contribute to ...

Data Bridge Market Research has recently published the comprehensive business research on recombinant technology Market includes historic data, present market trends, future product environment, ...

Absolute Antibody Ltd., an industry-leading manufacturer of recombinant antibodies, has developed custom protein purification systems to significantly increase its antibody production throughput. The ...

Amy Sheng (left) is Head of the CRO Program at Sino Biological US Inc. (PA, USA), and has expertise in cell, molecular biology, immunology and biochemistry. In this interview, Amy discusses the ...

Researchers at the USC School of Pharmacy indicate that recombinant DNA technology may allow for oral administration of drugs that previously could only be given by injection. LOS ANGELES, May 6 - ...